Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

1HFS

CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THE N-CARBOXY-ALKYL INHIBITOR L-764,004

Summary for 1HFS
Entry DOI10.2210/pdb1hfs/pdb
DescriptorSTROMELYSIN-1, ZINC ION, CALCIUM ION, ... (5 entities in total)
Functional Keywordshydrolase, metalloprotease, matrix metalloprotease-3, proteoglycanase
Biological sourceHomo sapiens (human)
Cellular locationSecreted, extracellular space, extracellular matrix : P08254
Total number of polymer chains1
Total formula weight18902.83
Authors
Becker, J.W. (deposition date: 1997-02-13, release date: 1998-02-18, Last modification date: 2024-02-07)
Primary citationEsser, C.K.,Bugianesi, R.L.,Caldwell, C.G.,Chapman, K.T.,Durette, P.L.,Girotra, N.N.,Kopka, I.E.,Lanza, T.J.,Levorse, D.A.,MacCoss, M.,Owens, K.A.,Ponpipom, M.M.,Simeone, J.P.,Harrison, R.K.,Niedzwiecki, L.,Becker, J.W.,Marcy, A.I.,Axel, M.G.,Christen, A.J.,McDonnell, J.,Moore, V.L.,Olszewski, J.M.,Saphos, C.,Visco, D.M.,Shen, F.,Colletti, A.,Krieter, P.A.,Hagmann, W.K.
Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.
J.Med.Chem., 40:1026-1040, 1997
Cited by
PubMed Abstract: Carboxyalkyl peptides containing a biphenylylethyl group at the P1' position were found to be potent inhibitors of stromelysin-1 (MMP-3) and gelatinase A (MMP-2), in the range of 10-50 nM, but poor inhibitors of collagenase (MMP-1). Combination of a biphenylylethyl moiety at P1', a tert-butyl group at P2', and a methyl group at P3' produced orally bioavailable inhibitors as measured by an in vivo model of MMP-3 degradation of radiolabeled transferrin in the mouse pleural cavity. The X-ray structure of a complex of a P1-biphenyl inhibitor and the catalytic domain of MMP-3 is described. Inhibitors that contained halogenated biphenylylethyl residues at P1' proved to be superior in terms of enzyme potency and oral activity with 2(R)-[2-(4'-fluoro-4-biphenylyl)ethyl]-4(S)-n-butyl-1,5-pentane dioic acid 1-(alpha(S)-tert-butylglycine methylamide) amide (L-758,354, 26) having a Ki of 10 nM against MMP-3 and an ED50 of 11 mg/kg po in the mouse pleural cavity assay. This compound was evaluated in acute (MMP-3 and IL-1 beta injection in the rabbit) and chronic (rat adjuvant-induced arthritis and mouse collagen-induced arthritis) models of cartilage destruction but showed activity only in the MMP-3 injection model (ED50 = 6 mg/kg iv).
PubMed: 9083493
DOI: 10.1021/jm960465t
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.7 Å)
Structure validation

238895

数据于2025-07-16公开中

PDB statisticsPDBj update infoContact PDBjnumon